DE3931041C2
(en)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
|
DE4108393A1
(en)
*
|
1991-03-15 |
1992-09-17 |
Boehringer Ingelheim Kg |
NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
|
US5770738A
(en)
*
|
1992-03-05 |
1998-06-23 |
Boehringer Ingelheim Kg |
Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
|
DE19921693A1
(en)
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
|
US7214687B2
(en)
|
1999-07-14 |
2007-05-08 |
Almirall Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
ES2165768B1
(en)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
|
GB0009606D0
(en)
*
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Therapeutic combinations
|
GB0009592D0
(en)
*
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory combinations
|
GB0009583D0
(en)
*
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory formulations
|
GB0009605D0
(en)
*
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Medicaments
|
US6777400B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
US6858593B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
US6777399B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
US6787532B2
(en)
|
2000-08-05 |
2004-09-07 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivatives
|
US6750210B2
(en)
|
2000-08-05 |
2004-06-15 |
Smithkline Beecham Corporation |
Formulation containing novel anti-inflammatory androstane derivative
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
GB0019172D0
(en)
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
AR032471A1
(en)
|
2000-08-05 |
2003-11-12 |
Glaxo Group Ltd |
DERIVED FROM ANDROSTAN AND SOLVATOS OF THE SAME, ITS USE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCESSES TO PREPARE SUCH DERIVATIVES, USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH DERIVATIVES, PROCESSES TO PREPARE SUCH INTERMEDIATES
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
BR0107304A
(en)
|
2000-10-12 |
2002-08-13 |
Boehringer Ingelheim Pharma |
Inhalation powder containing tiotropium
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
GEP20063905B
(en)
*
|
2000-10-12 |
2006-08-25 |
Boehringer Ingelheim Pharma |
Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
|
PT1333819E
(en)
*
|
2000-10-31 |
2007-10-29 |
Boehringer Ingelheim Pharma |
Inhalative solution formulation containing a tiotropium salt
|
DE10064816A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Boehringer Ingelheim Pharma |
Production of tiotropium bromide useful as an anticholinergic comprises oxidation of di-(2-thienyl)-glycolic acid tropenol ester and subsequent quaternisation
|
CA2433128C
(en)
|
2000-12-28 |
2010-05-25 |
Almirall Prodesfarma Ag |
Novel quinuclidine derivatives and medicinal compositions containing the same
|
US6506900B1
(en)
|
2001-01-31 |
2003-01-14 |
Boehringer Ingelheim Pharma Ag |
Process for preparing a scopine ester intermediate
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
CA2445839A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
DE10126924A1
(en)
*
|
2001-06-01 |
2002-12-05 |
Boehringer Ingelheim Pharma |
Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
|
EE05316B1
(en)
*
|
2001-06-22 |
2010-08-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Crystalline anticholinergic, a process for its preparation and its use in the manufacture of a medicament
|
US6608055B2
(en)
|
2001-06-22 |
2003-08-19 |
Boehringer Ingelheim Pharma Kg |
Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
|
US6610849B2
(en)
*
|
2001-06-28 |
2003-08-26 |
Boehringer Ingelheim Pharma Kg |
Process for the manufacture of tropenol
|
DE10141377A1
(en)
|
2001-08-23 |
2003-03-13 |
Boehringer Ingelheim Pharma |
Scattering process for the production of powder formulations
|
BR0206207A
(en)
|
2001-10-26 |
2003-12-23 |
Pharmacia & Up John Company |
Quaternary ammonium compounds and their use as antimuscarinic agents
|
DE10200943A1
(en)
*
|
2002-01-12 |
2003-07-24 |
Boehringer Ingelheim Pharma |
Process for the preparation of scopine esters
|
DE10203749A1
(en)
*
|
2002-01-31 |
2003-08-14 |
Boehringer Ingelheim Pharma |
New anticholinergics, process for their preparation and their use as medicines
|
US6696462B2
(en)
|
2002-01-31 |
2004-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
|
GB0202635D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Wellcome Mfg Pte Ltd |
Formulation containing novel anti-inflammatory androstane derivative
|
GB0203193D0
(en)
*
|
2002-02-11 |
2002-03-27 |
Pfizer Ltd |
Nicotinamide derivatives useful as pde4 inhibitors
|
WO2003068233A1
(en)
*
|
2002-02-11 |
2003-08-21 |
Pfizer Limited |
Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
|
US7309707B2
(en)
*
|
2002-03-20 |
2007-12-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
|
DE10212264A1
(en)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament
|
US7244415B2
(en)
|
2002-03-28 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations of an anhydrate
|
DE10214264A1
(en)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA suspension formulations of an anhydrate
|
UA80123C2
(en)
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
DE10216036A1
(en)
|
2002-04-11 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Aerosol formulation for inhalation containing a tiotropium salt
|
DE10224091A1
(en)
*
|
2002-05-31 |
2003-12-11 |
Boehringer Ingelheim Pharma |
Technical process for the production of tropenol
|
GB2389530B
(en)
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
US7763280B2
(en)
|
2002-11-28 |
2010-07-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing powder formulation for inhalation
|
CA2513188A1
(en)
*
|
2003-01-16 |
2004-08-05 |
University Of Rochester |
Quaternary antimuscarinic compounds for the treatment of bladder diseases
|
US20040226556A1
(en)
|
2003-05-13 |
2004-11-18 |
Deem Mark E. |
Apparatus for treating asthma using neurotoxin
|
WO2004106333A1
(en)
|
2003-05-28 |
2004-12-09 |
Theravance, Inc. |
Azabicycloalkane compounds as muscarinic receptor antagonists
|
CN101407514B
(en)
*
|
2003-11-03 |
2013-05-29 |
贝林格尔.英格海姆国际有限公司 |
Tiotropium salts, tiotropium salts pharmaceutical formulations and uses thereof
|
US7968717B2
(en)
|
2003-11-03 |
2011-06-28 |
Boehringer Ingelhein International Gmbh |
Crystalline anhydrate with anticholinergic efficacy
|
EP2083007B1
(en)
*
|
2003-11-03 |
2013-04-24 |
Boehringer Ingelheim International Gmbh |
Tiotropium salts, method for creating same and medicinal formulations containing same
|
JP4553902B2
(en)
*
|
2003-11-03 |
2010-09-29 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Novel crystalline anhydride with anticholinergic action
|
SE0303570L
(en)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Moisture-sensitive medical product
|
US20080027094A1
(en)
*
|
2004-08-30 |
2008-01-31 |
Ono Pharmaceutical Co., Ltd. |
Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient
|
DK1881980T3
(en)
|
2005-05-02 |
2012-10-01 |
Boehringer Ingelheim Int |
New crystalline forms of tiotropium bromide
|
EP1879888A2
(en)
*
|
2005-05-02 |
2008-01-23 |
Boehringer Ingelheim International GmbH |
Crystalline forms of tiotropium bromide
|
DE102005035112A1
(en)
|
2005-07-27 |
2007-02-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
A new process for the preparation of tiotropium salts using N-methylscopinium salts soluble in organic solvents
|
NZ566068A
(en)
|
2005-08-08 |
2011-03-31 |
Argenta Discovery Ltd |
Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
|
TWI389692B
(en)
|
2005-10-10 |
2013-03-21 |
Boehringer Ingelheim Int |
Aerosol formulations for the inhalation of beta-agonists
|
DE102005059602A1
(en)
*
|
2005-12-14 |
2007-06-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Micronization process
|
US20070167480A1
(en)
*
|
2005-12-19 |
2007-07-19 |
Sicor Inc. |
Pure and stable tiotropium bromide
|
US9108962B2
(en)
|
2005-12-19 |
2015-08-18 |
Sicor, Inc. |
Forms of tiotropium bromide and processes for preparation thereof
|
CN102731494A
(en)
*
|
2005-12-19 |
2012-10-17 |
西科尔公司 |
Novel forms of tiotropium bromide and processes for preparation thereof
|
RS51703B
(en)
*
|
2006-01-04 |
2011-10-31 |
Boehringer Ingelheim International Gmbh. |
Use of tiotropium salts in the treatment of moderate persistent asthma
|
ES2298049B1
(en)
|
2006-07-21 |
2009-10-20 |
Laboratorios Almirall S.A. |
PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO.
|
CA2659539A1
(en)
|
2006-08-01 |
2008-02-07 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
|
EP1923393A1
(en)
*
|
2006-11-17 |
2008-05-21 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Crystalline form of tiotropium bromide and urea
|
EP1925295A1
(en)
*
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stable powder formulation containing a new antichinolinergic agent
|
GB0716026D0
(en)
|
2007-08-16 |
2007-09-26 |
Norton Healthcare Ltd |
An inhalable medicament
|
CA2608561A1
(en)
*
|
2007-10-29 |
2009-04-29 |
Carl Paluszkiewicz |
Motorcycle wind deflector accessory support
|
WO2009087419A1
(en)
*
|
2008-01-10 |
2009-07-16 |
Generics [Uk] Limited |
Novel process for the preparation of scopine esters
|
US8483831B1
(en)
|
2008-02-15 |
2013-07-09 |
Holaira, Inc. |
System and method for bronchial dilation
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
WO2009137819A1
(en)
|
2008-05-09 |
2009-11-12 |
Innovative Pulmonary Solutions, Inc. |
Systems, assemblies, and methods for treating a bronchial tree
|
EP2172190A1
(en)
|
2008-10-02 |
2010-04-07 |
Laboratorios Liconsa, S.A. |
Inhalable particles comprising tiotropium
|
WO2010101538A2
(en)
|
2009-03-06 |
2010-09-10 |
Bilgic Mahmut |
New crystal forms
|
ES2774391T3
(en)
*
|
2009-05-29 |
2020-07-20 |
Pearl Therapeutics Inc |
Compositions, methods and systems for the respiratory administration of two or more active agents
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
WO2011015884A1
(en)
|
2009-08-07 |
2011-02-10 |
Generics [Uk] Limited |
Process to prepare scopine esters
|
AU2010280497B2
(en)
|
2009-08-07 |
2015-10-22 |
Generics [Uk] Limited |
Anhydrate of tiotropium bromide
|
WO2011015883A1
(en)
|
2009-08-07 |
2011-02-10 |
Generics [Uk] Limited |
Dichloromethane solvate of tiotropium bromide and its use
|
TR200907237A2
(en)
|
2009-09-23 |
2011-04-21 |
Bi̇lgi̇ç Mahmut |
Tiotropium dry powder combination
|
TR200907236A2
(en)
|
2009-09-23 |
2011-04-21 |
Bi̇lgi̇ç Mahmut |
Transport of Tiotropium dry powder formulation in blister pack.
|
KR101722290B1
(en)
|
2009-10-27 |
2017-03-31 |
호라이라 인코포레이티드 |
Delivery devices with coolable energy emitting assemblies
|
US8911439B2
(en)
|
2009-11-11 |
2014-12-16 |
Holaira, Inc. |
Non-invasive and minimally invasive denervation methods and systems for performing the same
|
EP4111995A1
(en)
|
2009-11-11 |
2023-01-04 |
Nuvaira, Inc. |
Device for treating tissue and controlling stenosis
|
WO2011093812A2
(en)
|
2010-01-28 |
2011-08-04 |
Mahmut Bilgic |
Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
|
WO2011093810A2
(en)
|
2010-01-28 |
2011-08-04 |
Bilgic Mahmut |
Dry powder pharmaceutical composition comprising tiotropium and mometasone
|
TR200909792A2
(en)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Dry powder combination containing tiotropium, corticosteroid and a combination of chromoglycic acid derivative
|
TR201000681A2
(en)
*
|
2010-01-29 |
2011-08-22 |
B�Lg�� Mahmut |
Dry powder formulations inhaled.
|
TR200909788A2
(en)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Dry powder formulation suitable for inhalation with tiotropium
|
US8834931B2
(en)
|
2009-12-25 |
2014-09-16 |
Mahmut Bilgic |
Dry powder formulation containing tiotropium for inhalation
|
TR200909790A2
(en)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Combination of dry powder containing a combination of tiotropium, formoterol and a chromoglycic acid derivative.
|
TR200909793A2
(en)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.
|
WO2011093809A2
(en)
|
2010-01-28 |
2011-08-04 |
Mahmut Bilgic |
Dry powder pharmaceutical composition comprising tiotropium and ciclesonide
|
TR200909789A2
(en)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Dry powder combination containing tiotropium, budesonide and a chromoglycic acid derivative combination
|
TR201000679A2
(en)
*
|
2010-01-29 |
2011-08-22 |
B�Lg�� Mahmut |
Dry powder formulations containing a pharmaceutical combination.
|
EP2528600B1
(en)
|
2010-01-28 |
2016-06-29 |
Mahmut Bilgic |
Dry powder pharmaceutical composition comprising tiotropium and fluticasone
|
TR201000733A2
(en)
|
2010-02-02 |
2011-08-22 |
Bi̇lgi̇ç Mahmut |
Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate.
|
US8957209B2
(en)
|
2010-04-01 |
2015-02-17 |
Mahmut Bilgic |
Methods for the synthesis of tiotropium bromide
|
TR201005222A2
(en)
|
2010-04-01 |
2011-10-21 |
Bi̇lgi̇ç Mahmut |
Tiotropium bromide synthesis method
|
TR201002520A2
(en)
|
2010-04-01 |
2010-05-21 |
Bi̇lgi̇ç Mahmut |
Tiotropium bromide manufacturing method.
|
TR201005221A2
(en)
|
2010-04-01 |
2012-01-23 |
Bi̇lgi̇ç Mahmut |
Improved synthesis method.
|
TR201007108A2
(en)
|
2010-08-25 |
2012-03-21 |
B�Lg�� Mahmut |
New tiotropium bromide crystal and production method.
|
TR201101897A2
(en)
|
2011-02-28 |
2012-09-21 |
Bi̇lgi̇ç Mahmut |
Crystal material containing tiotropium bromide
|
TR201102068A2
(en)
|
2011-03-03 |
2012-09-21 |
Bi̇lgi̇ç Mahmut |
Crystalline substances containing tiotropium bromide
|
TR201111589A2
(en)
|
2011-03-03 |
2012-09-21 |
Bi̇lgi̇ç Mahmut |
Tiotropium bromide anhydrous crystal form.
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
ITRM20110508A1
(en)
|
2011-09-27 |
2013-03-28 |
Lusochimica Spa |
PROCESS FOR THE PREPARATION OF SCOPINA'S ESTERS.
|
US8680297B2
(en)
|
2011-10-06 |
2014-03-25 |
Drug Process Licensing Assoc., LLC |
Manufacturing process for tiotropium bromide
|
CZ304368B6
(en)
|
2011-11-28 |
2014-04-02 |
Zentiva, K.S. |
Tiotropium bromide mixed solvate and process for preparing thereof
|
GB201200525D0
(en)
|
2011-12-19 |
2012-02-29 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhalable medicament
|
RS55996B1
(en)
*
|
2011-12-22 |
2017-09-29 |
Cerbios-Pharma S A |
Continuous process for the alkylation of cyclic tertiary amines
|
WO2013109216A2
(en)
|
2012-01-16 |
2013-07-25 |
Mahmut Bilgic |
Preparation of dry powder formulations comprising tiotropium
|
CZ201241A3
(en)
|
2012-01-20 |
2013-07-31 |
Zentiva, K.S. |
Novel polymorphous forms of thiotropium iodide and process for preparing thereof
|
PT106142B
(en)
*
|
2012-02-10 |
2014-07-18 |
Hovione Farmaci Ncia S A |
PROCESS FOR THE PREPARATION OF TIOTROPE BROMIDE
|
US20150165038A1
(en)
|
2012-02-10 |
2015-06-18 |
Arven llac Sanayi Ve Ticaret A.S. |
Compositions comprising muscarinic receptor antagonist and sorbitol
|
WO2013127738A1
(en)
|
2012-02-28 |
2013-09-06 |
Boehringer Ingelheim International Gmbh |
Novel propellant-gas-containing tiotropium formulation
|
CZ304808B6
(en)
*
|
2012-03-16 |
2014-11-05 |
Zentiva, K.S. |
Process for preparing scopine ester of di-(2- thienyl)glycolic acid, an intermediate in the synthesis of tiotropium bromide and a new form thereof
|
CZ305012B6
(en)
*
|
2012-03-30 |
2015-03-25 |
Zentiva, K.S. |
Process for preparing scopine ester of di-(2-thienyl)glycolic acid, an intermediate in the synthesis of tiotropium bromide
|
WO2014007771A2
(en)
|
2012-07-05 |
2014-01-09 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Inhalation compositions comprising muscarinic receptor antagonist
|
WO2014007769A1
(en)
|
2012-07-05 |
2014-01-09 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Compositions comprising muscarinic receptor antagonist and glucose anhydrous
|
EP2705838A1
(en)
|
2012-09-06 |
2014-03-12 |
Xspray Microparticles Ab |
Tiotropium preparations
|
MX2015005319A
(en)
|
2012-11-05 |
2015-07-14 |
Zentiva K S |
Stabilization of tiotropium solvates.
|
US9398933B2
(en)
|
2012-12-27 |
2016-07-26 |
Holaira, Inc. |
Methods for improving drug efficacy including a combination of drug administration and nerve modulation
|
RU2696582C2
(en)
|
2013-03-15 |
2019-08-05 |
Перл Терапьютикс, Инк. |
Methods and systems for conditioning disperse crystalline materials
|
JP6473738B2
(en)
|
2013-04-01 |
2019-02-20 |
パルマトリックス,インコーポレイテッド |
Tiotropium dry powder
|
EP2913332A1
(en)
*
|
2014-02-27 |
2015-09-02 |
Euticals S.P.A. |
Crystalline form of tiotropium bromide with lactose
|
US10034866B2
(en)
|
2014-06-19 |
2018-07-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Inhalable medicament comprising tiotropium
|
EP3297607B1
(en)
|
2015-05-18 |
2020-07-22 |
Glenmark Specialty S.A. |
Tiotropium inhalation solution for nebulization
|
US9987260B2
(en)
|
2015-05-18 |
2018-06-05 |
Glenmark Specialty S.A. |
Tiotropium inhalation solution for nebulization
|
US10653683B2
(en)
|
2015-05-18 |
2020-05-19 |
Glenmark Specialty S.A. |
Tiotropium inhalation solution for nebulization
|
KR101748796B1
(en)
|
2015-09-30 |
2017-06-19 |
한미약품 주식회사 |
Inhalation capsule with enhanced delivery rate of active ingredients
|
EP3159277B1
(en)
|
2015-10-23 |
2019-05-29 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Blister for inhalable formulation of tiotropium bromide
|
WO2017068119A1
(en)
|
2015-10-23 |
2017-04-27 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Blister for tiotropium bromide inhalable formulation
|
WO2017138896A1
(en)
|
2016-02-11 |
2017-08-17 |
Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti |
Crystalline form of tiotropium bromide anhydrate
|
CN106467535A
(en)
*
|
2016-08-28 |
2017-03-01 |
杭州百诚医药科技股份有限公司 |
One kind prepares the purifying process of 2,2 pairs of (2 thienyl) glycolic Rhizoma Scopoliae Japonicae esters
|
WO2018055642A1
(en)
*
|
2016-09-23 |
2018-03-29 |
Gbr Laboratories Pvt. Ltd. |
A process for preparing tiotropium bromide and intermediates thereof
|
MX2019004366A
(en)
|
2016-10-14 |
2019-08-05 |
Glenmark Specialty Sa |
Nebulizable compositions of tiotropium and formoterol.
|
EP3541369A4
(en)
|
2016-11-16 |
2020-06-10 |
Glenmark Specialty S.A. |
Nebulized tiotropium
|
US20200215051A1
(en)
|
2019-01-03 |
2020-07-09 |
Glenmark Specialty S.A. |
Nebulization composition comprising tiotropium and indacaterol
|
IL309888A
(en)
|
2021-07-09 |
2024-03-01 |
Astrazeneca Pharmaceuticals Lp |
Compositions, methods and systems for aerosol drug delivery
|
CN114213408B
(en)
*
|
2021-12-15 |
2023-03-31 |
台州仙琚药业有限公司 |
Preparation method of tiotropium bromide
|
WO2023119093A1
(en)
|
2021-12-20 |
2023-06-29 |
Astrazeneca Ab |
Compositions, methods and systems for aerosol drug delivery
|